RIRana Hashem Ibrahim

Rana Hashem Ibrahim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rana Hashem Ibrahim has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating the relation between serum apolipoprotein B (apo B), apolipoprotein A (apo A) and apo B/apo A ratio with diabetic retinopathy in a sample of type 2 Egyptian diabetic patient

    by Salwa Seddik Hosny, Merhan Samy Nasr, Moataz M. W. Abd Elfattah, Samar Helmy Abdel Dayem, Rana Hashem Ibrahim

    Background: Diabetic retinopathy (DR) is a chronic progressive, ocular disease affecting the retinal microvasculature accompanied by hyperglycaemia and different situations related to diabetes mellitus (DM) such as hypertension (HTN). Till now, the majority of researches demonstrated an insignificant correlation between lipid profile parameters and DR. Novel serum lipid markers (apolipoproteins) which are the protein portion of lipoproteins were recently linked to DR, and observed that the increased apo B and high apo B/apo A ratio accompanied by a higher possibility of proliferative DR. Aim: To assess the relation between novel serum lipid markers and various grades of DR in a sample of type 2 Egyptian diabetic cases. Methods: This study comprised 80 cases with type 2 diabetes mellitus (T2DM) divided into 3 groups: T2DM cases with proliferative diabetic retinopathy (PDR) (group I), T2DM cases with non-PDR (group II) and T2DM cases without DR as a control group (group III). Fasting plasma glucose (FPG), 2-h postprandial plasma glucose (2hpp), haemoglobinA1c (HbA1c), cholesterol (chol), triglycerides (TG), LDL, HDL and serum apolipoprotein A and B level. Complete medical history was taken from entire cases with a special focus on the duration of HTN and diabetes and full clinical examination (including BP and BMI). Results: There was a significant difference regarding serum apo B, apo B/apo A ratio, TG, total chol, LDL (pp=0.002), HTN duration (p=0.014), SBP (p=0.006), DBP (p=0.013), BMI (p=0.050) and HbA1c (p=0.025), being higher in group I than group II than group III; also, there was a significant difference between them with regard to serum apo A (p=0.010), and HDL (p=0.047) being higher in group III than group II than group I. On comparing group I with group II using Post hock Tukey’s test there was a significant difference regarding serum apo B (p=.023) and apo B/apo A ratio (p=.002). There was a statistically significant positive correlation between serum apo B/apo A ratio and diabetic duration (r=0.248), HTN d (r=0.4), HbA1c (r=.47), LDL (r=0.68), triglycerides (r=0.52), cholesterol (r=0.70) and a statistically significant negative correlation between serum apo B/apo A ratio and HDL (r=0.37) in all subjects. In addition, HTN duration was demonstrated to be the most independent factor affecting B/A ratio. Conclusion: Serum apo B and serum apo B/apo A ratio in diabetic cases are higher in the presence of retinopathy, triglycerides, total cholesterol, LDL, and HDL, and it is also higher in proliferative than non-proliferative diabetic retinopathy. The current study emphasizes on the potential correlation between the high serum apo B, serum apo B/apo A ratio and the advancement of DR.


  • Prevalence of Thyroiditis Following Either COVID -19 Infection or Vaccination in a Group of Egyptian (Hashimoto and Normal) Cases

    by Khaled Mahmoud Makboul, Laila Mahmoud Ali Hendawy, Hany Khairy Mansour, Menna Allah Adel Mohammed, Rana Hashem Ibrahim

    Background: Hashimoto's thyroiditis (HT), one of the most common autoimmune thyroid diseases (AITDs), is the major cause of hypothyroidism in the world's iodine-sufficient regions. The Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) causes COVID-19 illness, belong to the family of beta-coronaviruses which rapidly spread leading to COVID-19 pandemic on March 11, 2020. Since follicular thyroid cells express the angiotensin converting enzyme 2 (ACE2), the virus's receptor for cellular entry, they may serve as a direct target for SARS-CoV-2 infection. Objective: The aim of the current work was to evaluate the thyroid function consequences following either (COVID-19) infection or vaccination in group of Hashimoto thyroiditis and normal subjects in relation to their clinical features, biochemical, immunological, and inflammatory markers. Patients and Methods: This study was conducted on 80 subjects attending the COVID Vaccination Center and Emergency Isolation at Ain Shams University Hospital during the period from August to October 2022, 14 males, and 66 females, their age ranged from 18 to 70 years. They were divided according to thyroid Abs into Hashimoto’s thyroiditis group and normal group, each of them divided into 2 subgroups (exposed to COVID 19 infection & got COVID 19 vaccine). Results: This study showed significant increase in the level of TSH and decrease in the level of free T3, Free T4 in Hashimoto’s patients who exposed to COVID19 infection (P-value <0,01). Significant decrease in the level of TSH and increase in the level of free T3, Free T4 in Hashimoto’s subjects’ group after their exposure to COVID19 vaccine (AstraZeneca) (P-value <0,01), normal subjects group after exposure to COVID19 infection (P-value .02 and <0,01) and normal subjects group after being exposed to COVID19 vaccine (AstraZeneca) (P-value .02 and .04). Conclusion: COVID19 infection and vaccination against COVID might be followed by an attack of thyroiditis in Hashimoto patients and even in normal persons.

  • Open Access

    Effect of Ramadan Fasting on Microvascular Complications in Type 1 Diabetic Patients

    by Manal Mohammed Abushady, Yara Mohamed Eid, Doaa Eid Abd El-Sayed, Rana Hashem Ibrahim

    Background: Ramadan holy month fasting is part of Muslims faith that involves abstaining from food and drink intake as well as oral and injected medications from the dawn to dusk. An appreciable percent of type 1 diabetic patients insists on Ramadan fasting though exempted religiosly and medically. Objective: To evaluate the effect of Ramadan fasting primarily on eGFR and microalbuminuria in people with type 1 diabetes and secondarily on neuropathy and retinopathy. Patients and Methods: This study was conducted on 60 type 1 diabetic patients with microalbuminuria intending to fast Ramadan. Patients were recruited from diabetes outpatient clinics at Ain Shams University; all patients were on mutiple daily insulin injection (MDI). Before and after Ramadan fasting blood glucose (FBG), 2hPPBG, HbA1c%, fructosamine, Serum creatinine, BUN, urinary albumin/creatinine ratio (UAC ratio) and estimated GFR were measured to all patients in addition to fundus examination and DN4 questionnaire. Results: Among 60 patients who joined the study, 53 patients completed the study visits. The end of Ramadan fasting follow up showed a significant rise of serum creatinine and UAC ratio (0.87±0.14 vs 0.93±0.16 mg/dl, p=0.003; 125.5±101.1 vs 132.7±107.8 ugm/mg creatinine, p=0.003), while systolic and diastolic blood pressure showed no significant change (p=0.56; 0.58 respectively). Fifty percent of the patients exhibited a significant decrease of eGFR after Ramadan fasting (96.3±21.5 vs 89.7±22.7 ml/min/1.73 m2, p= 0.002). There was no difference across all studied variables upon subgrouping of patients according to eGFR state (Decreased, stationary and increased). There was a significant improvement of glycemic parameters, FBS (p < 0.001), post-prandial blood sugar (PPBS) (p < 0.001) and fructosamine (p= 0.02) with a significant reduction in hypoglycemic attacks by the end of Ramadan. Conclusion: Ramadan fasting decreased eGFR but within normal range among 50% of the studied population with a significant increase of UAC ratio inspite of improved glycemia.